Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jatinder Lamba

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2003
The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancerFred F Kadlubar, Gertrud S Berkowitz, Robert R Delongchamp, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2003
Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphismsHongXia Zheng, Steven Webber, Adriana Zeevi, et al.
JCO Precision Oncology|October 2, 2025
Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AMLSubodh Selukar, Harrison Clement, Yonghui Ni, et al.
Clinical Pharmacology and Therapeutics|December 13, 2005
Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5Stéphane J Mouly, Chris Matheny, Mary F Paine, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 11, 2003
Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expressionVishal Lamba, Jatinder Lamba, Kazuto Yasuda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategiesBoon-Cher Goh, Soo-Chin Lee, Ling-Zhi Wang, et al.
Mayo Clinic Proceedings|March 6, 2012
Germline predictors of androgen deprivation therapy response in advanced prostate cancerManish Kohli, Shaun M Riska, Douglas W Mahoney, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 22, 2006
Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450Piyush M Vyas, Sanjoy Roychowdhury, Farah D Khan, et al.
Journal of Clinical Pharmacology|January 30, 2004
Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphismHongXia Zheng, Adriana Zeevi, Erin Schuetz, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Dual Targeting of IKKβ and NR4A1 for AML TherapyChandra K Maharjan, Yi Liu, Yufeng Xiao, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2003
The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancerFred F Kadlubar, Gertrud S Berkowitz, Robert R Delongchamp, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2003
Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphismsHongXia Zheng, Steven Webber, Adriana Zeevi, et al.
JCO Precision Oncology|October 2, 2025
Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AMLSubodh Selukar, Harrison Clement, Yonghui Ni, et al.
Clinical Pharmacology and Therapeutics|December 13, 2005
Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5Stéphane J Mouly, Chris Matheny, Mary F Paine, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 11, 2003
Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expressionVishal Lamba, Jatinder Lamba, Kazuto Yasuda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategiesBoon-Cher Goh, Soo-Chin Lee, Ling-Zhi Wang, et al.
Mayo Clinic Proceedings|March 6, 2012
Germline predictors of androgen deprivation therapy response in advanced prostate cancerManish Kohli, Shaun M Riska, Douglas W Mahoney, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 22, 2006
Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450Piyush M Vyas, Sanjoy Roychowdhury, Farah D Khan, et al.
Journal of Clinical Pharmacology|January 30, 2004
Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphismHongXia Zheng, Adriana Zeevi, Erin Schuetz, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Dual Targeting of IKKβ and NR4A1 for AML TherapyChandra K Maharjan, Yi Liu, Yufeng Xiao, et al.
Pageof 4